[
    "epts for Drug Discovery and Development, Kluwer Academic Publishers, Boston, 1992, pp. 35-87; Corbett, et al., Cancer Res., 1984, 44, 717-726.; and LoRusso, et al., Cancer Res., 1990, 50, 4900-4905.</p>T/C ValueThis is tumor growth inhibition, where T is the medium tumor burden in the treatment group times 100 at evaluation and C is the medium tumor burden in the control group at evaluation. A T/C value &lt;42% is considered significant antitumor activity.</p>MTDThis is the maximum tolerated total dose administered intravenously in mg/kg.</p>LTCThis means the long term cures, the number of mice in the treatment group with no palpable tumor evidents after a minimum of 86 days/total number in treatment group.</p>LCKThis means log<sub>10</sub> cell kill of tumor bearing mice (cures excluded), a calculation based on tumor growth delay; cures for this tumor require &gt;4.5 log kill.</p>__________________________________________________________________________\nin vitro    topo II                                                       \n                 inter-                                                   \n                      murine antitumor activity                           \ncytox       inhib                                                         \n                 calation                                                 \n                      versus Panc 03                                      \nCompound                                                                  \n      IC50-\u03bcM                                                          \n            EC.sub.50 -\u03bcM                                              \n                 EC.sub.50 -\u03bcM                                         \n                      % T/C                                               \n                          MTD LTC LCK                                     \n__________________________________________________________________________\nEx 5  0.33  &gt;260 1.5  0   81  0/5 2.4                                     \nEx 6  55    &gt;240 1.9  0   231 3/5 3.6                                     \nEx 8  5.8   &gt;250 0.12 25.sup.j                                            \n                          72  0/5 m                                       \nEx 9  13    &gt;260 0.13 0.sup.j                                             \n                          240 3/4 &gt;4.5                                    \nEx 11 0.5   &gt;230 1.8  0   72  0/5 2.31                                    \nEx 12 30    &gt;210 1.6  0   208 3/5 2.2                                     \nEx 15 0.0044                                                              \n            0.55.sup.k                                                    \n                 2.4  0.sup.j                                             \n                          31  0/5 2.0                                     \nEx 13 0.50  &gt;240 2.6  0   78  3/5 2.5                                     \nEx 14 45    &gt;220 0.79 0.sup.j                                  "
]